Formant

Robot command center that lets customers deploy faster, scale while reducing overhead, and maximize the value of a robot fleet and the data it produces.

Check Point Software Technologies, Ltd.

Check Point Software Technologies Ltd. (www.checkpoint.com) is a leading provider of cyber security solutions to governments and corporate enterprises globally. Check Point’s solutions protect customers from 5th generation cyber-attacks with an industry leading catch rate of malware, ransomware and advanced targeted threats. Check Point offers a multilevel security architecture, “Infinity Total Protection with Gen V advanced threat prevention”, this combined product architecture defends an enterprises’ cloud, network and mobile devices. Check Point provides the most comprehensive and intuitive one point of control security management system. Check Point protects over 100,000 organizations of all sizes.

Airspace Systems Inc.

About Airspace Systems Airspace uses AI and advanced robotics to create fully automated, always-on solutions that deliver the three mandatory requirements of airspace security: long-range detection, instant identification, and safe capture and removal of unauthorized or malicious drones. Airspace solutions protect people, property, and IP for businesses, law enforcement, and the military. All Airspace solutions are mobile, modular, and simple to operate. Founded in San Francisco in 2015, Airspace is funded by early investors in Nest, Palantir, and Skype. Mission Autonomous airspace security. Vision Safe and secure skies open for business and social good.

Twenty Twenty Therapeutics

Twenty Twenty Therapeutics is focused on harnessing the convergence of AI, microelectronics and scalable digital technologies with diagnostic and preventative eye care to bring innovative solutions for eye diseases to market. Our vision is to eliminate preventable blindness. By transforming the delivery of today's eye-care, we are improving patient access to intuitive and affordable diagnostics and treatments. We believe it should be easy for doctors to deliver superior outcomes to their patients. Our technology empowers patients to care for their own vision in between doctors visits. To accomplish these goals, we develop, market and commercialize transformative innovations in diagnostics, sensing, and preventative / medical / surgical treatments for eye diseases. We were formed in August 2020 as a joint venture between Verily Life Sciences, an Alphabet company, and Santen, a leading Japanese pharmaceutical company. We are passionate and committed to building and sustaining an inclusive and equitable working environment. Every member on our team enriches our diversity by exposing us to a broad range of views that help us understand and engage with the world, identify challenges, and to discover, design and deliver solutions. The Twenty Twenty work environment empowers our team to do their absolute best work.